Nuwellis Inc (NUWE)

Currency in USD
1.740
-2.710(-60.90%)
Closed·
1.770+0.030(+1.72%)
·
Unusual trading volume
Trading near 52-week Low
NUWE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.6101.930
52 wk Range
1.610316.050
Key Statistics
Prev. Close
4.45
Open
1.74
Day's Range
1.61-1.93
52 wk Range
1.61-316.05
Volume
6.87M
Average Volume (3m)
2.31M
1-Year Change
-99.4537%
Book Value / Share
40.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NUWE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Nuwellis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.000

Nuwellis Inc Earnings Call Summary for Q1/2026

  • Nuwellis Q1 2026 revenue rose 26% YoY to $2.4M; gross margin improved to 70.1% from 56.1%, but net loss widened to $4.3M.
  • Operating expenses surged to $6.0M from $4.1M YoY; stock trades at $1.06, near 52-week low, down 97.5% over past year.
  • Company targets 50% reduction in monthly cash burn by Q4 2026 amid concerns over rapid cash depletion and rising costs.
  • Plans 2027 launch of integrated kidney monitoring product following Rendiatech acquisition to strengthen cardiorenal care position.
  • CEO Erb highlights pediatric and adult critical care growth; company focuses on operational discipline and South Texas territory expansion.
Last Updated: 2026-05-12, 11:12 a/m
Read Full Transcript

Earnings

Latest Release
May 12, 2026
EPS / Forecast
-2.09 / --
Revenue / Forecast
2.4M / 2.09M
EPS Revisions
Last 90 days

NUWE Income Statement

Compare NUWE to Peers and Sector

Metrics to compare
NUWE
Peers
Sector
Relationship
P/E Ratio
0.0x−2.7x−0.4x
PEG Ratio
-−0.100.00
Price/Book
0.1x2.7x2.6x
Price / LTM Sales
0.0x2.7x3.0x
Upside (Analyst Target)
-64.4%56.0%
Fair Value Upside
Unlock5.5%9.1%Unlock

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.11K0.76%1.93K
Other Institutional Investors
63.33K43.20%110.19K
Public Companies & Retail Investors
82.14K56.04%142.93K
Total
146.58K100.00%255.05K

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Armistice Capital LLC20.57%30,15752
Armistice Capital Master Fund Ltd.20.57%30,15752

People Also Watch

0.3739
SNGX
-0.29%
0.486
ATYR
+1.25%
1.20
YYGH
-4.00%
1.1700
SBFM
-4.88%
2.095
XOS
+3.71%

FAQ

What Is the Nuwellis (NUWE) Stock Price Today?

The Nuwellis stock price today is 1.740 USD.

What Stock Exchange Does Nuwellis Trade On?

Nuwellis is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nuwellis?

The stock symbol for Nuwellis is "NUWE."

What Is the Nuwellis Market Cap?

As of today, Nuwellis market cap is 255.050K USD.

What Is Nuwellis's Earnings Per Share (TTM)?

The Nuwellis EPS (TTM) is -563.486.

From a Technical Analysis Perspective, Is NUWE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nuwellis Stock Split?

Nuwellis has split 12 times.

How Many Employees Does Nuwellis Have?

Nuwellis has 38 employees.

What is the current trading status of Nuwellis (NUWE)?

As of Aug 03, 2026, Nuwellis (NUWE) is trading at a price of 1.740 USD, with a previous close of 4.450 USD. The stock has fluctuated within a day range of 1.610 USD to 1.930 USD, while its 52-week range spans from 1.610 USD to 316.050 USD.

What Is the NUWE Premarket Price?

NUWE's last pre-market stock price is 1.790 USD. The pre-market share volume is 2,750,000.000, and the stock has decreased by -2.660, or -59.780%.

What Is the NUWE After Hours Price?

NUWE's last after hours stock price is 1.770 USD, the stock has decreased by 0.030, or 1.720%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.